Menu
GeneBe

4-2818281-G-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The ENST00000511747.6(SH3BP2):c.58G>T(p.Asp20Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,031,960 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000061 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

SH3BP2
ENST00000511747.6 missense

Scores

3
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.733
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13167244).
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000612 (9/147144) while in subpopulation EAS AF= 0.00177 (9/5098). AF 95% confidence interval is 0.00092. There are 1 homozygotes in gnomad4. There are 6 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SH3BP2NM_001122681.2 linkuse as main transcriptc.-4-2333G>T intron_variant ENST00000503393.8
SH3BP2NM_001145856.2 linkuse as main transcriptc.58G>T p.Asp20Tyr missense_variant 1/13
SH3BP2NM_001145855.2 linkuse as main transcriptc.81-2333G>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SH3BP2ENST00000503393.8 linkuse as main transcriptc.-4-2333G>T intron_variant 1 NM_001122681.2 P2P78314-1

Frequencies

GnomAD3 genomes
AF:
0.0000612
AC:
9
AN:
147044
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00176
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000147
AC:
13
AN:
884816
Hom.:
0
Cov.:
29
AF XY:
0.0000145
AC XY:
6
AN XY:
412626
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00182
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000612
AC:
9
AN:
147144
Hom.:
1
Cov.:
32
AF XY:
0.0000838
AC XY:
6
AN XY:
71636
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00177
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000140

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 15, 2023The c.58G>T (p.D20Y) alteration is located in exon 1 (coding exon 1) of the SH3BP2 gene. This alteration results from a G to T substitution at nucleotide position 58, causing the aspartic acid (D) at amino acid position 20 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
Cadd
Benign
12
Dann
Benign
0.90
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.42
T
M_CAP
Pathogenic
0.78
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.89
T
MutationTaster
Benign
1.0
D;D;D;D;D;N
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.18
Sift
Pathogenic
0.0
D
Vest4
0.17
MutPred
0.26
Loss of loop (P = 0.0235);
MVP
0.34
MPC
0.20
ClinPred
0.15
T
GERP RS
0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1304494768; hg19: chr4-2820008; API